Skip to search.
 STI Down1.77%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM

7.88 23 May 04:00 SGT

Add to Portfolio
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Jun 13		Next Qtr.
Sep 13		Current Year
Dec 13		Next Year
Dec 14
Avg. Estimate-0.10-0.08-0.320.08
No. of Analysts8.008.008.008.00
Low Estimate-0.12-0.13-0.40-0.40
High Estimate-0.060.15-0.070.84
Year Ago EPS-0.02-0.08-0.32-0.32
Revenue EstCurrent Qtr.
Jun 13		Next Qtr.
Sep 13		Current Year
Dec 13		Next Year
Dec 14
Avg. EstimateNaN2.50M9.50M53.52M
No. of Analysts8888
Low EstimateNaNNaN7.00M10.20M
High EstimateNaN20.00M27.00M92.35M
Year Ago SalesNaNNaNNaN9.50M
Sales Growth (year/est)N/AN/AN/A463.40%
Earnings HistoryJun 12Sep 12Dec 12Mar 13
EPS Est-0.09-0.07-0.08-0.01
EPS Actual-0.02-0.08-0.09-0.03
Difference0.07-0.01-0.01-0.02
Surprise %77.80%-14.30%-12.50%-200.00%
EPS TrendsCurrent Qtr.
Jun 13		Next Qtr.
Sep 13		Current Year
Dec 13		Next Year
Dec 14
Current Estimate-0.10-0.08-0.320.08
7 Days Ago-0.10-0.08-0.320.08
30 Days Ago-0.08-0.08-0.250.02
60 Days Ago-0.08-0.07-0.230.02
90 Days Ago-0.06-0.06-0.190.20
EPS RevisionsCurrent Qtr.
Jun 13		Next Qtr.
Sep 13		Current Year
Dec 13		Next Year
Dec 14
Up Last 7 Days0000
Up Last 30 Days0111
Down Last 30 Days0000
Down Last 90 DaysN/AN/AN/AN/A
Growth EstKERXIndustrySectorS&P 500
Current Qtr.-400.00%N/AN/A11.80%
Next Qtr.0.00%N/AN/A16.60%
This Year0.00%N/A9.70%9.10%
Next Year125.00%N/A13.20%12.60%
Past 5 Years (per annum)0.00%N/AN/AN/A
Next 5 Years (per annum)30.00%13.14%13.69%9.37%
Price/Earnings (avg. for comparison categories)-26.47-0.683.1113.41
PEG Ratio (avg. for comparison categories)-0.88-5.56-0.771.34
Currency in USD.